AIM
RIGL icon

AXA Investment Managers’s Rigel Pharmaceuticals RIGL Stock Holding History

AXA Investment Managers’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$923K Buy
+32,594
New +$975K ﹤0.01% 907

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXA Investment Managers's RIGL Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2025: 32,594 shares worth $923K. The stake represents ﹤0.01% of the portfolio and ranks #907 among its holdings.

169 funds tracked by Wall St. Rank hold RIGL as of Q3 2025.

  • AXA Investment Managers held 32,594 shares of Rigel Pharmaceuticals worth $923K as of Q3 2025.
  • Rigel Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
  • Rigel Pharmaceuticals made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #907 holding.
  • 169 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.